Cargando…
P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621567/ http://dx.doi.org/10.1097/01.HS9.0000890632.73921.fb |
_version_ | 1784821587464159232 |
---|---|
author | Dragičević, Ida Hude Bašić-Kinda, Sandra Dujmović, Dino Radman, Ivo Dreta, Barbara Dotlić, Sandra Galunić-Bilić, Lea Dobrenić, Margareta Kralik, Marko Rončević, Pavle Aurer, Igor |
author_facet | Dragičević, Ida Hude Bašić-Kinda, Sandra Dujmović, Dino Radman, Ivo Dreta, Barbara Dotlić, Sandra Galunić-Bilić, Lea Dobrenić, Margareta Kralik, Marko Rončević, Pavle Aurer, Igor |
author_sort | Dragičević, Ida Hude |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9621567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-96215672022-11-01 P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP) Dragičević, Ida Hude Bašić-Kinda, Sandra Dujmović, Dino Radman, Ivo Dreta, Barbara Dotlić, Sandra Galunić-Bilić, Lea Dobrenić, Margareta Kralik, Marko Rončević, Pavle Aurer, Igor Hemasphere Advanced Stages Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621567/ http://dx.doi.org/10.1097/01.HS9.0000890632.73921.fb Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Advanced Stages Dragičević, Ida Hude Bašić-Kinda, Sandra Dujmović, Dino Radman, Ivo Dreta, Barbara Dotlić, Sandra Galunić-Bilić, Lea Dobrenić, Margareta Kralik, Marko Rončević, Pavle Aurer, Igor P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP) |
title | P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP) |
title_full | P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP) |
title_fullStr | P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP) |
title_full_unstemmed | P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP) |
title_short | P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP) |
title_sort | p016: reduced steroid exposure is safe and does not reduce disease control among hodgkin lymphoma patients treated with escalated beacopp (ebeacopp) |
topic | Advanced Stages |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621567/ http://dx.doi.org/10.1097/01.HS9.0000890632.73921.fb |
work_keys_str_mv | AT dragicevicidahude p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp AT basickindasandra p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp AT dujmovicdino p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp AT radmanivo p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp AT dretabarbara p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp AT dotlicsandra p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp AT galunicbiliclea p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp AT dobrenicmargareta p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp AT kralikmarko p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp AT roncevicpavle p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp AT aurerigor p016reducedsteroidexposureissafeanddoesnotreducediseasecontrolamonghodgkinlymphomapatientstreatedwithescalatedbeacoppebeacopp |